GKB Ophthalmics Quarterly Results for Trading Insights

In Sept 2025, GKB Ophthalmics (GKB) reported revenue ₹31 Cr and net profit ₹2 Cr — revenue +19.2% YoY. For annual financials, live price and key ratios, visit GKB Ophthalmics share price chart.

Latest Quarter Net Profit
₹2 Cr
QSept 2025
Quarterly Results

GKB Quarterly Results — Revenue, Profit & EPS Highlights

GKB Ophthalmics latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with GKB Ophthalmics valuation methods to assess whether the stock is under or overvalued.

  • Revenue of ₹31 Cr in Sept 2025 (+0.0% vs Mar 2025, +19.2% vs Sept 2024)
  • Net Profit of ₹2 Cr in Sept 2025 (+150.0% vs Mar 2025, +300.0% vs Sept 2024)
  • EBITDA of ₹3 Cr in Sept 2025 (+200.0% vs Mar 2025)
  • Operating Margin of 10.0% in Sept 2025 (+19.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.17 in Sept 2025 (+145.1% vs Mar 2025)

GKB Ophthalmics Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GKB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 31 31 33 58 26 - 19.2%
Net Profit (₹ Cr) 2 -4 -1 1 -1 - -
EBITDA (₹ Cr) 3 -3 1 2 0 - -
EPS (₹) 3.17 -7.03 -2.02 0.08 -2.41 - -
Operating Margin (%) 10.0% -9.0% 2.0% 2.0% 0.0% - -

GKB Share Price Trend — 1-Year Movement Across Quarterly Results

GKB Ophthalmics 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse GKB shareholding pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 6.5%
EBITDA Margin 9.7%
Operating Margin 10.0%
ROE (Annual) 14.3%

Balance Sheet Highlights

Total Assets ₹125 Cr
Total Equity ₹56 Cr
Current Assets ₹99 Cr
Current Liabilities ₹6 Cr

Cash Flow Analysis

Operating Cash Flow ₹-3 Cr
Investing Cash Flow ₹3 Cr
Financing Cash Flow ₹1 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹67.17
Exchange BSE
Last Updated Apr 28, 2026

Revenue Trend (₹ Cr)

Dec 2025 58
Jun 2025 33
Mar 2025 31
Sept 2025 31

Net Profit Trend (₹ Cr)

Dec 2025 1
Jun 2025 -1
Mar 2025 -4
Sept 2025 2

Operating Margin Trend (%)

Dec 2025 2.0%
Jun 2025 2.0%
Mar 2025 -9.0%
Sept 2025 10.0%

GKB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

GKB Ophthalmics latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹415,924.72 Cr 1747.3 14,875 3,125 +10.8% - 21.0% 134.4
Divis Laboratories
Sept 2025 		₹171,625.44 Cr 6432.5 2,860 689 +7.1% - 24.1% 247.7
Torrent Pharmaceuti…
Sept 2025 		₹139,344.76 Cr 4182.9 3,219 591 +11.3% - 18.4% 238.5
Dr Reddys Laborator…
Sept 2025 		₹109,930.83 Cr 1354.6 9,135 1,337 +1.1% - 14.6% 83.7
Lupin
Sept 2025 		₹104,941.69 Cr 2302.7 6,921 1,485 +23.2% - 21.5% 71.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores